NDC 60505-4915 - Norethindrone and ethinyl estradiol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-4915
- Manufacturer
- Apotex Corp. | Naari Pte Limited | Naari Pharma Private Limited
- Effective date
- 2025-12-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NORETHINDRONE - Apotex Corp. | Naari Pte Limited | Naari Pharma Private Limited | Apotex Corp. | Naari Pte Limited | Naari Pharma Private Limited | 2025-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Incassia | NORETHINDRONE | Aurobindo Pharma Limited | 0b87cef0-610c-469d-92ba-4007f4bc3878 | 2021-09-14 | Warnings, Adverse reactions | T18F433X4S |
| Norethindrone | NORETHINDRONE | Proficient Rx LP | fb84b86e-5f1f-4c17-8b69-ff695c5faf55 | 2019-11-01 | Warnings, Adverse reactions | T18F433X4S |
| NORETHINDRONE | NORETHINDRONE | Mylan Pharmaceuticals Inc. | af851d82-b30f-463b-9dba-0437225dc1ee | 2018-10-23 | Boxed warning, Warnings, Adverse reactions | T18F433X4S |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.